Cabergoline.

The article describes the case of a 47-year-old woman with a pituitary prolactinoma condition, who developed pathological gambling during treatment with cabergoline. The patient's intake of cabergoline was stopped when she was diagnosed with pathological gambling and major depression with paranoid delusions. She started treatment with escitalopram that led to improved mood two months later and resolution of her gambling and paranoid delusions.